Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ACAD
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

ACADIA Pharmaceuticals Inc. (ACAD) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ACADIA Pharmaceuticals (ACAD) trades at $19.78, up 1.02% today, amid mixed signals. The stock shows strong fundamental improvement with 2025 revenue reaching $1.07B and net income of $391M, yielding a net margin of 36.49%. However, technical indicators are bearish, and recent Phase II Alzheimer's trial results for remlifanserin missed the primary endpoint, causing volatility. Positive developments include European approval for Daybue and a patent extension to 2041.
The outlook is cautiously optimistic. Strong profitability and analyst consensus (70% buy ratings) with a $32.32 price target suggest upside potential, but clinical trial setbacks and a bearish technical trend present near-term risks. Investment appeal hinges on successful Phase III development of remlifanserin and continued commercial execution.
Read full analysis

Key Stats

  • Market Cap
    $3.41B
  • Volume
    1,470,247
  • Sector
    Health
  • 52W High
    $30.57
  • 52W Low
    $19.41
  • Typical Hold Time
    77 Days
  • Enterprise Value
    $2.53B
  • Div Yield
    -
  • Trading Activity
    -
$19.17
52W Low: $19.17
13 Oct 2026
52W High: $30.57
25 Aug 2026

Track ACADIA Pharmaceuticals Inc. (ACAD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $19.17 and a high of $30.57, highlighting its annual price range. Buy and sell ACADIA Pharmaceuticals Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Most Recent News

Content is generated by Aura AI

US Rental Business Census 2026 counts 128,188 rental listings, revealing state-by-state rental market insights.

The US Rental Business Census 2026 by Reservety reports 128,188 rental business listings across 12 categories in all US states and D.C., identifying about 114,235 unique businesses with 98,123 independent operators. Wyoming leads with the highest ren...

Market News
46 minutes ago
Not Specified
Neutral
US Rental Business Census 2026 counts 128,188 rental listings, revealing state-by-state rental market insights.

New 'BadEngram' attack exposes hidden risks in open-weight AI models' memory components

Researchers from Pillar Security and Fujitsu revealed 'BadEngram,' a stealthy supply-chain attack targeting the gated memory components in open-weight AI models like Qwen3.8-Flash-Next and DeepSeek-V4.1-Flash. This attack implants a hidden backdoor b...

Market News
46 minutes ago
Not Specified
Bearish
news icon
New 'BadEngram' attack exposes hidden risks in open-weight AI models' memory components

APAC sustainable data center market to hit $57.18B by 2031, driven by AI, renewables, and advanced cooling tech.

The Asia-Pacific sustainable data center market is projected to grow from $16.74 billion in 2025 to $57.18 billion by 2031, at a CAGR of 22.7%. Growth is fueled by rising demand for AI, cloud computing, and hyperscale infrastructure, prompting invest...

Market News
1 hour ago
Researchandmarkets.Com
Bullish
news icon
APAC sustainable data center market to hit $57.18B by 2031, driven by AI, renewables, and advanced cooling tech.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $3.41B
  • Volume
    1,470,247
  • Sector
    Health
  • 52W High
    $30.57
  • 52W Low
    $19.41
  • Typical Hold Time
    77 Days
  • Enterprise Value
    $2.53B
  • Div Yield
    -
  • Trading Activity
    -
$19.17
52W Low: $19.17
13 Oct 2026
52W High: $30.57
25 Aug 2026

Track ACADIA Pharmaceuticals Inc. (ACAD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $19.17 and a high of $30.57, highlighting its annual price range. Buy and sell ACADIA Pharmaceuticals Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!